NeuroOne Medical Technologies Corporation (NMTC) Gross margin 2021–2025
NeuroOne Medical Technologies Corporation (NMTC) gross margin by fiscal year — reported gross profit divided by reported revenue.
56.5%FY2025 · since FY2021: -54.9% → 56.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 56.5% | +25.2 pp |
| FY2024 | 31.3% | +7.9 pp |
| FY2023 | 23.4% | +64.7 pp |
| FY2022 | -41.4% | +13.5 pp |
| FY2021 | -54.9% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice